[1]
2021. Predictive role of CCND1, FGFR1 gene amplifications and PIK3CA mutations for endocrine therapy of primary metastatic breast cancer . Voprosy onkologii. 67, 5 (Oct. 2021), 646–657. DOI:https://doi.org/10.37469/0507-3758-2021-67-5-646-657.